EM-Tech Decides to Absorb Fully-Owned Subsidiary BSL via No-Stock Merger, No Impact on Shareholder Value
EM-Tech decided to absorb its wholly-owned subsidiary BSL in a no-stock merger. No new shares are issued, so the total shares outstanding and capital remain unchanged, resulting in no dilution for existing shareholders.
BSL had negative equity of 34.96 billion KRW and a net loss of 1.39 billion KRW as of end-2025. The merger aims to improve management efficiency and create healthcare synergy, effectively cleaning up the subsidiary's poor financials.
Despite opposition from shareholders holding 10.97% of total shares, the merger was approved by the board under small-scale merger rules without a shareholder meeting. No appraisal rights were granted.
[AI Summary]EM-Tech's no-stock merger with BSL simplifies the corporate structure without diluting shareholder value, but the absorption of BSL's negative equity offers no immediate earnings upside. Short-term stock impact is limited; long-term synergy in healthcare sector is key.
KOSDAQ Filing Information
Other Management Matters (Voluntary Disclosure) - Report on Result of Board Resolution Approving Small-Scale Merger (In Lieu of Shareholders' Meeting)